Study on the Effect of Incentive Spirometer-based Respiratory Training on the Long COVID-19

Launched by NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES · Jan 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of using an incentive spirometer, a device that helps improve breathing, for people experiencing long-term symptoms after recovering from COVID-19. Many individuals who have had COVID-19 report ongoing issues such as fatigue, difficulty breathing, and chest discomfort, which can seriously affect their quality of life. The goal of the trial is to see if this breathing training can help ease these symptoms and improve overall health.

To participate in this study, you must have recovered from COVID-19 within the past year and be aged between 20 and 90. You should not have a history of heart disease, diabetes, or hypertension and must have long-term respiratory symptoms related to COVID-19. Participants will need to be able to understand Mandarin or Taiwanese, as this is the language used in the study. If you qualify and choose to join, you will be assigned to use the incentive spirometer and monitored for any improvements in your symptoms. This research aims to find effective ways to help those struggling with the lasting effects of COVID-19.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Individuals who have contracted and recovered from COVID-19 within the past year must present proof of diagnosis, such as medical certificates or screening results. The ICD-10 diagnosis codes are: U07.1 for confirmed COVID-19 viral infection, and U09.0 for post-COVID-19 condition, unspecified. Recovery is defined as testing negative in a COVID-19 rapid test.
• • 2. Never diagnosed with hypertensive diseases (ICD-10 codes: I10.x or I11.x), diabetes (ICD-10 codes: E10.x or E11.x), or heart diseases (ICD-10 codes: I25.x, I50.x, I65.x, or I67.x and classified as Class I or II by the New York Heart Association functional classification).
• • 3. Exhibiting long-term respiratory symptoms related to COVID-19, such as post-exertional breathlessness, chest discomfort, cough, difficulty breathing, rapid breathing, etc., and meeting at least one of these criteria for inclusion.
• • 4. Aged between 20 - 90 years.
• • 5. Able to communicate in and understand Mandarin or Taiwanese, either verbally or non-verbally.
• • 6. Willing to participate in the study and agree to be assigned.
• Exclusion Criteria:
• • 1. Patients with a functional status classified as level 5 or higher on the Modified Rankin Scale (MRS), indicating severe disability and bedridden status.
• • 2. Patients suffering from dementia, such as Alzheimer's, Parkinson's disease, etc.
• • 3. Patients with acute psychiatric symptoms who are unable to communicate.
• • 4. Individuals with a high risk of litigation.
• • 5. Patients suffering from Chronic Obstructive Pulmonary Disease (COPD) or any other respiratory system diseases.
• • 6. Patients with moderate or severe heart disease, classified as Class III or IV by the New York Heart Association functional classification.
• • -